Retinoids in oncology.
Mahrle
G
G
D000818:Animals; D002273:Carcinogens / Q000037:antagonists & inhibitors; D002280:Basal Cell Carcinoma / Q000188:drug therapy; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy; D003043:Cocarcinogenesis; D004790:Enzyme Induction / Q000187:drug effects; D006801:Humans; D007636:Keratoacanthoma / Q000188:drug therapy; D007642:Keratosis / Q000188:drug therapy; D008223:Lymphoma / Q000188:drug therapy; D008545:Melanoma / Q000188:drug therapy; D009374:Neoplasms, Experimental / Q000517:prevention & control*; D009955:Ornithine Decarboxylase / Q000096:biosynthesis; D027383:Papillomaviridae; D012176:Retinoids / Q000627:therapeutic use*; D012878:Skin Neoplasms / Q000188:drug therapy*
D002273:Carcinogens; D012176:Retinoids; D009955:Ornithine Decarboxylase